How to Buy Adverum Biotechnologies Stock
Adverum Biotechnologies Inc
Adverum Biotechnologies, Inc. , a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases.
Adverum Biotechnologies stock last closed at $11.15, down 1.76% from the previous day, and has increased 22.54% in one year. It has overperformed other stocks in the Biotechnology industry by 0.49 percentage points. Adverum Biotechnologies stock is currently +57.04% from its 52-week low of $7.10, and -62.46% from its 52-week high of $29.70.
There are currently 20.75M ADVM shares outstanding. The market capitalization of ADVM is $231.42M. In the last 24 hours, 103,592 ADVM shares were traded.
How to Buy Adverum Biotechnologies Stock
Not sure how to invest in Adverum Biotechnologies stock? Here's how.
- Choose where to buy Adverum Biotechnologies stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Adverum Biotechnologies stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Select your payment method and add your details.
- Research Adverum Biotechnologies stock: The Adverum Biotechnologies ticker symbol is ADVM. Is Adverum Biotechnologies stock a good investment? Should you buy shares of ADVM? How do ADVM's underlying business fundamentals look? Do top analysts think Adverum Biotechnologies is a good buy? Why has ADVM's stock price moved recently? (Hint: Our stock analysis website can help you figure out if ADVM is a good stock to buy).
- Make your ADVM trade: Decide if you will purchase ADVM shares at the current market price or use a limit order to purchase ADVM stock at a specific price.
- Get the latest news on your investment in ADVM: Create a watchlist to important updates regarding your investment in Adverum Biotechnologies stock.
Step 1: Choose where to buy Adverum Biotechnologies stock
You need an online brokerage account to access the NASDAQ market and buy ADVM stock.
Our recommended brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to global markets: From Tech to Real Estate, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the best brokerage, the next step is to fill out some personal details so you can buy ADVM today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new brokerage account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've finished signing up on our top ranked stock trading app, you can securely and quickly fund your account:
Check out the tutorial below for more details depositing money into your new brokerage account.
Step 4: Research Adverum Biotechnologies stock
Once you have decided on the best place to buy Adverum Biotechnologies stock, it's important to research their stock prior to buying, so you can comprehend the risk as well as the upside.
Adverum Biotechnologies shares data
ADVM Zen Score
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ADVM's stock page.
Is ADVM stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge ADVM's fair value.
Using relative valuations ratios:
- ADVM may be undervalued based on its P/B ratio of 2.77x, relative to Biotechnology industry P/B ratio of 5.76x
You can access additional valuation research on ADVM's stock here.
ADVM Financial Health Overview
Signs that ADVM is financially healthy:
- ADVM has cash burn of 91710000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the ADVM balance sheet.
- There are more short-term assets than long-term liabilities on the ADVM balance sheet.
Signs that ADVM is not financially healthy:
- ADVM profit margin has gone down from N/A to -3,254.6% in the past year.
- ADVM has a relatively high debt to equity ratio of 1.07.
- ADVM has $98.50M in cash and short term investments. This is not sufficient to cover its annual cash burn of $91.71M.
- Total ADVM debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy ADVM stock
Out of 3 Equities analysts who give forecasts on ADVM, the consensus analyst rating on ADVM is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are saying on the Adverum Biotechnologies stock forecast page.
ADVM Trading Indicators
ADVM Performance Metrics
Last year, ADVM revenue was $3.60M. During the last 5 year, ADVM's revenue has gone up by 17.43% per year. This was slower than the Biotechnology industry average of 28.98%.
Learn more about ADVM's earnings and revenue performance here.
Latest Insiders Trades at ADVM
In the last 12 months, executives and large shareholders at ADVM have bought more shares than they have sold.
Jr Mark L. Lupher, Director of ADVM, was the latest ADVM insider to buy. They bought $175,500.00 worth of ADVM shares on Feb 7, 2024.
Dig into more about who owns ADVM shares here.
Does ADVM stock generate passive income?
No, Adverum Biotechnologies doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your ADVM trade
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at an exact price, use a limit order.
Click the Open button and your broker will execute your order.
If you need additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get the latest news on your investment in ADVM
Now that you own some ADVM shares, you'll want to keep up with your stock purchase.
Add ADVM to a watchlist to get notified of important updates regarding your ADVM stock.
ADVM Feed
How to Buy Stock in Adverum Biotechnologies
To summarize, here are the 6 steps to buy Adverum Biotechnologies stock:
- Choose where to buy Adverum Biotechnologies stock
- Open your brokerage account
- Put funds into your brokerage account
- Research Adverum Biotechnologies stock
- Make your ADVM trade
- Get the latest news on your investment in ADVM
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your new investment in Adverum Biotechnologies, add ADVM to your watchlist by clicking the button below.
Other Articles You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.